By attaching specialised molecules to the backbone of DNA, researchers have made it easier to detect rare molecules associated with early disease.
The presence of, or changes in the concentration of, certain proteins in biological fluids can be indicators of disease. However, in the early stages of disease these ‘biomarkers’ can be difficult to detect, as they are relatively rare.
We have now shown that this is possible to perform such measurements in real human samples, opening up the potential for meaningful early diagnosis.
– Dr Alex Ivanov
Detecting important biomarkers in lower concentrations will allow patients to be treated earlier for diseases such as some cancers and neurological disorders, which could increase the chance of survival rate.
However, current methods of detection are often not sufficiently sensitive and require costly and time-consuming sample pre-treatment.
Now, researchers from the Department of Chemistry at Imperial College London have come up with a system that is specific, flexible, and can detect single protein biomarkers directly in human serum (a pool of fluid separated from blood).
The system represents a significant innovation, as it is more sensitive to specific biomarkers and does not require clinical sample preparation. The method is published in Nature Communications.
Dr Alex Ivanov, co-leader of this study from the Department of Chemistry at Imperial, said: “The detection of single molecules of biomarkers represents the ultimate in sensitivity for early diagnosis. We have now shown that this is possible to perform such measurements in real human samples, opening up the potential for meaningful early diagnosis.”
Binding to biomarkers
The method the team developed uses the ‘backbone’ of DNA, the structure it is built around. They grafted ‘aptamers’ – synthetic DNA molecules that bind to specific target biomarkers – to DNA backbones.
When added to human serum, the aptamers bind to biomarkers before being analysed by passing through a nanopore detector. Nanopores are miniscule holes (often as small as a few billionths of a meter) that measure a change in electrical current as molecules pass through them.
Each biomarker has a unique current signature, so the presence and concentration of target biomarkers can be analysed in this way.
With the rapid growth in nanotechnology and nanopore technology, this innovative platform could pave the way for the next wave of clinical applications.
– Dr Jasmine Sze
The team demonstrated that their system can work by testing three aptamers on one DNA backbone. They found that the nanopores can detect the specific biomarkers that the aptamers were designed to pick up.
They say that the system can be constructed with more than five different aptamers, allowing detection of multiple biomarkers at once. In addition, the biomarkers were detected in human serum, meaning far less preparation time and cost were needed.
Based on the preliminary findings of this study, research efforts are now focused on several types of cancer and neurological disorders, which can benefit from the detection of biomarkers that are in low abundance in clinical samples.
The team have filed a patent for the technology, and are currently exploring routes towards commercialisation so that it can be used to ultimately improve quality of life.
Dr Jasmine Sze, who completed this study as part of her PhD in the Department of Chemistry and has recently moved to the IMED Biotech at AstraZeneca said “Looking forward, with the rapid growth in nanotechnology and nanopore technology, this innovative platform could pave the way for the next wave of clinical applications.
“It has great potential for biomarker discovery, development of companion diagnostics as well as clinical endeavours, such as direct diagnosis, prognosis and sub-type classification with single-molecule sensitivity.”
The Latest on: Disease diagnosis
- Wines From France And California Raise Awareness For A Disease Called PANDASon October 9, 2020 at 8:21 am
To raise awareness for PANDAS, the disease that caused their daughter's death, Susan and Towny Manfull are using a method tested not by science, but by time: conversation over a glass of wine. They ...
- 86 percent of people with coronavirus cases in the U.K. showed no major symptomson October 9, 2020 at 7:16 am
Asymptomatic coronavirus cases may be far more common than we thought. A survey conducted by the U.K.'s Office for National Statistics revealed 86.1 percent of people who contracted COVID-19 between ...
- COVID-19 survivors already fight stigma; worry Trump’s diagnosis will make it worseon October 9, 2020 at 7:15 am
For a blip in history, Yvette Paz possessed the clout to shut down an entire hospital. Her magical power? Coronavirus. In mid-March, Paz, who had served in the Marines, became VA Long Beach ...
- Chase Winovich: Most Patriots might be fine after COVID-19, but it’s a ‘big gamble’ for families, symptoms ‘crapshoot’on October 9, 2020 at 7:06 am
The whole COVID situation is just a big gamble, in terms of it’s just like roulette," Winovich said, via ESPN’s Mike Reiss. "You don’t really know what your symptoms are going to be. I understand the ...
- Steelers Broadcaster Diagnosed With ALSon October 9, 2020 at 7:05 am
Steelers broadcaster and former offensive tackle Tunch Ilkin has announced he has ALS, also known as Lou Gehrig's disease. Ilkin, the Steelers radio color commentator, revealed he had the illness ...
- New research provides fresh hope for children suffering from rare muscle diseaseson October 9, 2020 at 6:51 am
Results of an international study published today in Autophagy and led by researchers from Monash University, School of Biological Sciences, provides renewed hope for children suffering from a ...
- Longtime Steelers Lineman, Broadcaster Diagnosed With ALSon October 9, 2020 at 6:23 am
Pittsburgh Steelers broadcaster and former offensive lineman Tunch Ilkin amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease. Ilkin announced the diagnosis in a video on ...
- Steelers Longtime Tackle And Current Broadcaster Tunch Ilkin Diagnosed With ALSon October 9, 2020 at 6:09 am
The former Steeler’s tackle and now current radio broadcaster Tunch Ilkin has been diagnosed with ALS. In a video released by The Bible Chapel, a non-denominational church in Pittsburgh where Ilkin is ...
- Former Steeler Tunch Ilkin diagnosed with ALS, plans to ‘fight’on October 9, 2020 at 6:01 am
Tunch Ilkin revealed Thursday that he has been diagnosed a week ago with ALS, commonly known as Lou Gehrig’s disease.
- Plain Talk: With Trump's COVID-19 diagnosis, will Wisconsin Republicans finally take the disease seriously?on October 7, 2020 at 6:00 am
If we want to get this horrendous and deadly virus under control, maybe we should be asking those we elected to be our leaders to show some responsibility, too.
via Google News and Bing News